Clinical trial
Efficacy and Safety of Shortening Dual Antiplatelet Therapy Duration with IVUS Guidance in PCI Patients: a Multicenter, Randomized Controlled Trial
NCT06648720 is registered in ClinicalTrials.gov with University Medical Center Ho Chi Minh City (UMC) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Shortening Dual Antiplatelet Therapy Duration with IVUS Guidance in PCI Patients: a Multicenter, Randomized Controlled Trial
- Lead sponsor
- University Medical Center Ho Chi Minh City (UMC)
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- March 1, 2025
- Completion date
- March 1, 2029
- Enrollment
- 3,566 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
coronary arterial disease (cad), dual antiplatelet therapy, intravascular ultrasound, percutaneous coronary intervention (pci)